Pricing Log in Create free account

IMMURON (IMRN) vs Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX)

IMMURON and Quoin Pharmaceuticals, Ltd. Sponsored ADR are both Biotechnology companies. IMMURON and Quoin Pharmaceuticals, Ltd. Sponsored ADR are of similar size ($8.3M and $8.1M). Quoin Pharmaceuticals, Ltd. Sponsored ADR has the higher net margin (0.00% vs −262.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, IMMURON leads on 6 and Quoin Pharmaceuticals, Ltd. Sponsored ADR on 3.

Valuation

Metric IMRN QNRX Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m 2.81 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.93 n/m 0.64
EV/Sales (3.47) n/m 9.21
Earnings yield (2.10%) (645.64%) (33.15%)
Free cash flow yield 0.00% (25.91%) (25.50%)

Profitability

Metric IMRN QNRX Biotechnology median
Gross margin 71.28% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin (262.71%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (575.73%) (56.36%)
Return on assets 0.00% (178.77%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMRN QNRX Biotechnology median
Revenue growth (TTM) (6.62%) — 6.02%
EPS growth (last fiscal year) 37.29% 77.84% 30.26%
Revenue growth, 5-year CAGR 116.96% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMRN QNRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.17 1.76 4.72
Net debt to EBITDA 1.81 1.16 0.96

Dividend

Metric IMRN QNRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IMRN QNRX Biotechnology median
Market cap 8.31m 8.10m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack